Recita 10 Mg/ 40 Mg 10 mg/ 40 mg TABLET
PDF Leaflet Revision Date: 18 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression, panic disorders, and OCD.
Dosage (summary)
Depression: 20 mg/day, max 40 mg. Panic disorder: 10 mg/day, increase to 20 mg. OCD: 20 mg/day, max 40 mg.
Onset of Action / Duration
Onset: 2-4 weeks
Special Populations
- Elderly: 10-20 mg/day
- Hepatic impairment: halve dose
- Renal impairment: mild/moderate no adjustment
Pregnancy & Breastfeeding
Safety in pregnancy/lactation not established; excreted in breast milk.
Key Drug Interactions
- MAOIs: contraindicated
- Serotonergic drugs: risk of serotonin syndrome
- Alcohol: increased effects
- Warfarin: increased anticoagulant effect
- Cimetidine: increased plasma levels
Contraindications
- Hypersensitivity to citalopram
- Concurrent MAOI use
- Severe renal impairment
- Congenital long QT syndrome
- Children under 18
Common side effects
- Nausea
- Dry mouth
- Sleep disturbances
- Somnolence
- QT prolongation
Counselling Points
- Take with or without food
- Do not abruptly discontinue
- Monitor for mood changes
- Avoid alcohol
Serious warnings
- Risk of suicidal ideation in patients with depression
- QT prolongation risk
- Monitor for serotonin syndrome
Important Disclaimer
The Recita 10 Mg/ 40 Mg 10 mg/ 40 mg TABLET professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
